Does COCARBOXYLASE Cause Product use in unapproved indication? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Product use in unapproved indication have been filed in association with COCARBOXYLASE. This represents 60.0% of all adverse event reports for COCARBOXYLASE.
9
Reports of Product use in unapproved indication with COCARBOXYLASE
60.0%
of all COCARBOXYLASE reports
0
Deaths
9
Hospitalizations
How Dangerous Is Product use in unapproved indication From COCARBOXYLASE?
Of the 9 reports, 9 (100.0%) required hospitalization.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for COCARBOXYLASE. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does COCARBOXYLASE Cause?
Drug ineffective (12)
Electrolyte imbalance (11)
Hypokalaemia (11)
Oedema peripheral (11)
Deafness bilateral (10)
Dizziness (10)
Pneumonia (10)
Pneumonia mycoplasmal (10)
Vertigo (10)
Otitis media (6)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)